SCHEDULE 13G 0000923093 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 10/06/2025 0001604950 scPharmaceuticals Inc. 810648105 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 Rule 13d-1(c) Tudor Investment Corporation DE 0.00 0.00 0.00 0.00 0.00 N 0 CO Paul T. Jones II X1 0.00 0.00 0.00 0.00 0.00 N 0 IN scPharmaceuticals Inc. 25 Mall Road, Suite 203, Burlington, Massachusetts 01803 This statement is filed by: Tudor Investment Corporation, a Delaware corporation ("Tudor"), which serves as investment manager to certain funds (the "Tudor Funds"), with respect to the shares of common stock, par value $0.0001 per share ("Common Stock"), of scPharmaceuticals Inc., a Delaware corporation, that were directly held by the Tudor Funds; and Paul T. Jones II ("Mr. Jones"), the Chief Investment Officer and indirect control person of Tudor, with respect to the shares of Common Stock that were directly held by the Tudor Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The address of the business office of each of the Reporting Persons is 200 Elm Street, Stamford, CT 06901. Tudor is a corporation organized under the laws of the State of Delaware. Mr. Jones is a United States citizen. Y The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. As of the date of the event which requires the filing of this Schedule 13G, the Reporting Persons may have been deemed to beneficially own more than 5% of the shares of Common Stock outstanding. 0% The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1: Joint Filing Agreement Tudor Investment Corporation /s/ Bronwyn Eckhardt 10/14/2025 Paul T. Jones II /s/ Paul T. Jones II 10/14/2025